As search interest in natural nerve health solutions reaches unprecedented levels in 2025, Nerve Soothe recently announced expanded nationwide distribution of its five-botanical formula, NerveSoothe ...
Stoke Therapeutics (NASDAQ:STOK) has enrolled first patient in a prospective natural history study of people ages 8 to 60 who are living with autosomal dominant optic atrophy (ADOA). FALCON is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback